HBV DNA is undetectable: why do I still need hepatitis B medicine?

After taking antiviral medicine for a while, you may feel relieved to see “HBV DNA not detected” on your report. A natural question follows: if the virus cannot be detected, can I stop treatment?

For someone receiving antiviral treatment for chronic hepatitis B, one undetectable HBV DNA result is not enough to decide that treatment can stop. Other markers, liver health, and results over time also matter. China chronic hepatitis B guideline, 2022

What does “not detected” mean?

No viral DNA was detected in that blood sample; this does not prove that HBV has been completely eliminated. “Below the quantification limit” is different: a report saying “<15 IU/mL, detected” means viral DNA was found, but could not be measured accurately. Read the full report. CDC laboratory guidance

Is undetectable DNA the same as losing surface antigen?

HBV DNA measures circulating viral replication. Hepatitis B surface antigen, or HBsAg, is a separate marker: undetectable DNA does not automatically mean HBsAg has disappeared.

Functional cure generally includes sustained HBsAg loss and undetectable HBV DNA after treatment ends. Viral genetic material may still remain in liver cells. Viral suppression, surface antigen loss, and complete viral elimination are different outcomes. China guideline: definitions

Why continue taking medicine?

Medicines such as entecavir and tenofovir suppress viral replication, slow cirrhosis progression, reduce liver cancer risk, and improve long-term survival. Better results can mean treatment is working. WHO notes that most people who start chronic hepatitis B treatment need to continue it for life. WHO hepatitis B fact sheet

Can anyone stop treatment?

Some carefully selected patients can. Guidelines differ; clinicians assess cirrhosis, HBeAg and HBsAg status, duration of viral suppression, and reliable follow-up. People with cirrhosis should be particularly cautious. Stopping can cause viral rebound, hepatitis flares, and sometimes liver decompensation. Any stopping plan must include monitoring and criteria for restarting treatment. EASL 2025 hepatitis B guideline

Action checklist: what to ask at your next visit

Continue your current prescription and bring previous reports. Ask your doctor:

• Was HBV DNA not detected, or detected below the quantification limit?
• What do my surface antigen, liver tests, and fibrosis assessment show?
• Do I meet the criteria to discuss stopping treatment?
• If I eventually stop, when will I have tests, and what would require restarting?

An undetectable result is encouraging. Work with your doctor to maintain the benefit you have achieved.

This article provides education about oral antiviral treatment for chronic hepatitis B, not an individual instruction to stop medicine. Preventive treatment during pregnancy or immunosuppression requires a separate assessment.